Federmann, Birgit <br/><br/>
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.  [electronic resource] 

 -  Haematologica  Oct 2012 
 - 1523-31 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2011.059378  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, CD19<br/>Antigens, CD34<br/>CD3 Complex<br/>Chimerism<br/>Female<br/>Graft Survival<br/>Graft vs Host Disease<br/>Haplotypes<br/>Hematologic Diseases--mortality<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Hematopoietic Stem Cells--metabolism<br/>Humans<br/>Leukemia--therapy<br/>Lymphocyte Depletion<br/>Lymphoma, Non-Hodgkin--therapy<br/>Major Histocompatibility Complex--genetics<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--therapy<br/>Myelodysplastic Syndromes--therapy<br/>Receptors, KIR--immunology<br/>Risk Factors<br/>Tissue Donors<br/>Transplantation Conditioning<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Young Adult